Drugs / Autologous Peripheral Blood Stem Cell
Autologous Peripheral Blood Stem Cell
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06364150 | Jul 2024 → May 2025 overdue | acute myocardial infarction | Seoul National Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Peripheral Blood Stem Cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06364150 ↗ |
| Modality | Cell therapy | “Biological: Autologous Peripheral Blood Stem Cell injection” NCT06364150 ↗ |
| Route | Other | “will be injected to the culprit artery” NCT06364150 ↗ |